Variant report

Variant	nsv1030927
Chromosome Location	chr6:162136159-162377828
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:31)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:31 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:162207547..162209957-chr6:162210445..162213994,3	K562	blood:
2	chr6:162291697..162293198-chr6:162305600..162307370,2	K562	blood:
3	chr6:162347118..162349182-chr6:162351860..162355211,3	K562	blood:
4	chr6:162135808..162138276-chr6:162142475..162145172,2	K562	blood:
5	chr20:46012429..46013123-chr6:162169752..162170322,2	MCF-7	breast:
6	chr6:162212614..162214396-chr6:162214709..162217609,2	MCF-7	breast:
7	chr6:162216587..162218691-chr6:162225101..162227602,2	K562	blood:
8	chr6:162258117..162258784-chr6:162338530..162339165,2	MCF-7	breast:
9	chr6:162258059..162258779-chr6:162552660..162553528,2	MCF-7	breast:
10	chr6:162350457..162353351-chr6:162353923..162356207,2	K562	blood:
11	chr6:162274815..162277621-chr6:162282085..162283805,2	K562	blood:
12	chr6:162313026..162315357-chr6:162317264..162319780,2	K562	blood:
13	chr6:162111336..162114011-chr6:162137192..162139483,2	K562	blood:
14	chr6:162216587..162218691-chr6:162225101..162227602,2	K562	blood:
15	chr6:162350457..162353351-chr6:162353923..162356207,2	K562	blood:
16	chr6:162347118..162349182-chr6:162351860..162355211,3	K562	blood:
17	chr6:162313026..162315357-chr6:162317264..162319780,2	K562	blood:
18	chr6:162274815..162277621-chr6:162282085..162283805,2	K562	blood:
19	chr6:162212614..162214396-chr6:162214709..162217609,2	MCF-7	breast:
20	chr6:162232298..162233805-chr6:162237071..162239613,2	K562	blood:
21	chr6:162372183..162373880-chr6:162375416..162378006,2	K562	blood:
22	chr6:162211723..162213448-chr6:162215614..162217575,2	K562	blood:
23	chr6:162291697..162293198-chr6:162305600..162307370,2	K562	blood:
24	chr6:162135808..162138276-chr6:162142475..162145172,2	K562	blood:
25	chr6:162211723..162213448-chr6:162215614..162217575,2	K562	blood:
26	chr6:162307888..162309501-chr6:162310852..162312650,2	K562	blood:
27	chr6:162232298..162233805-chr6:162237071..162239613,2	K562	blood:
28	chr6:162307888..162309501-chr6:162310852..162312650,2	K562	blood:
29	chr6:162207547..162209957-chr6:162210445..162213994,3	K562	blood:
30	chr6:162372183..162373880-chr6:162375416..162378006,2	K562	blood:
31	chr6:162258117..162258784-chr6:162338530..162339165,2	MCF-7	breast:

No data

Extended variants
information (count: 10615 )
Associated
traits (count: 98 )

Variant overlapped rSNPs/rCNVs (count:10615 , 50 per page) page: 1 2 3 4 5 6 7 ... 213

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs528015760	chr6:162137006-162137007	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs150650029	chr6:162137008-162137009	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs74700824	chr6:162137055-162137056	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs533346439	chr6:162137071-162137072	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs550314589	chr6:162137073-162137074	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs570073061	chr6:162137082-162137083	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs201931887	chr6:162137098-162137099	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs112078090	chr6:162137100-162137101	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs371148730	chr6:162137101-162137102	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs529360306	chr6:162137108-162137109	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs549124616	chr6:162137112-162137113	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs267600887	chr6:162137126-162137127	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs77332950	chr6:162137147-162137148	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs115815599	chr6:162137154-162137155	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs554103401	chr6:162137163-162137164	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs144108240	chr6:162137207-162137208	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs146475715	chr6:162137315-162137316	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs556274172	chr6:162137341-162137342	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs139975725	chr6:162137374-162137375	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs541896495	chr6:162137389-162137390	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs149732279	chr6:162137428-162137429	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs145617954	chr6:162137472-162137473	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs6921599	chr6:162137512-162137513	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs374365595	chr6:162137513-162137514	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs187578995	chr6:162137514-162137515	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs148835493	chr6:162137539-162137540	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs78895012	chr6:162137562-162137563	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs73783354	chr6:162137646-162137647	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs191907487	chr6:162137647-162137648	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs549476241	chr6:162137648-162137649	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs183009445	chr6:162137653-162137654	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs73783355	chr6:162137665-162137666	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs570759581	chr6:162137670-162137671	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs115293120	chr6:162137694-162137695	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs186636849	chr6:162137708-162137709	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs549747847	chr6:162137747-162137748	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs73783356	chr6:162137748-162137749	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs529111233	chr6:162137774-162137775	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs547664806	chr6:162137775-162137776	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs540229232	chr6:162137787-162137788	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs6925073	chr6:162137788-162137789	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs190117555	chr6:162137832-162137833	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs375662109	chr6:162137838-162137839	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs182390981	chr6:162137869-162137870	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs555368720	chr6:162137870-162137871	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs114823690	chr6:162137883-162137884	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs6925313	chr6:162137950-162137951	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs73013497	chr6:162137957-162137958	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs187452708	chr6:162137968-162137969	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs551735768	chr6:162138004-162138005	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:98)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Developmental delay	21147756	CNVD
Chordoma	18071362	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Breast cancer	16397240	CNVD
Atherosclerosis	21956041	CNVD
Maculopathy	20981449	CNVD
Retinoblastoma	22278416	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian cancer	20844748	CNVD
Uveal melanoma	20484589	CNVD
Glioblastoma multiforme	19435819	CNVD
Astrocytoma	16205629	CNVD
Parkinson disease	17160897	CNVD
Cancer	20164920	CNVD
Breast cancer	22522925	CNVD
Schizophrenia	20838587	CNVD
Early-onset parkinson disease	21993715	CNVD
Glioblastoma	18772890	CNVD
Pancreatic cancer	20981101	CNVD
Autism	21360662	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Intellectual disability	22102821	CNVD
Parkinson disease	0	CNVD
Bipolar disorder	19114987	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Schizophrenia	20967226	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Schizophrenia	23813976	CNVD

Chromatin state (count:976 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:162137000-162137400	Enhancers	Fetal Brain Male	brain
2	chr6:162137000-162138000	Enhancers	Cortex derived primary cultured neurospheres	brain
3	chr6:162137200-162138000	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
4	chr6:162137600-162138000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
5	chr6:162137800-162138400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr6:162138000-162143000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
7	chr6:162138000-162148200	Weak transcription	Cortex derived primary cultured neurospheres	brain
8	chr6:162138400-162139800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
9	chr6:162139800-162141000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
10	chr6:162141000-162141400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
11	chr6:162141400-162141600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
12	chr6:162141600-162148000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
13	chr6:162142200-162142800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
14	chr6:162142800-162148000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
15	chr6:162143000-162143200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
16	chr6:162147600-162148800	Enhancers	iPS-20b Cell Line	embryonic stem cell
17	chr6:162147800-162148400	Enhancers	ES-I3 Cell Line	embryonic stem cell
18	chr6:162147800-162148800	Enhancers	HUES6 Cell Line	embryonic stem cell
19	chr6:162148000-162148600	Enhancers	HUES64 Cell Line	embryonic stem cell
20	chr6:162148000-162148800	Enhancers	H1 Cell Line	embryonic stem cell
21	chr6:162148000-162148800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
22	chr6:162148000-162148800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
23	chr6:162148000-162148800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
24	chr6:162148000-162148800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
25	chr6:162148000-162148800	Enhancers	iPS-15b Cell Line	embryonic stem cell
26	chr6:162148000-162148800	Enhancers	iPS-18 Cell Line	embryonic stem cell
27	chr6:162148000-162149600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
28	chr6:162148200-162148600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
29	chr6:162148200-162148800	Enhancers	Cortex derived primary cultured neurospheres	brain
30	chr6:162148200-162149600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
31	chr6:162148800-162153600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
32	chr6:162148800-162157600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
33	chr6:162149600-162153800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
34	chr6:162153600-162154200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
35	chr6:162153800-162154400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
36	chr6:162154200-162157200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
37	chr6:162154400-162157000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
38	chr6:162157000-162158000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
39	chr6:162157200-162157600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
40	chr6:162157200-162157800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
41	chr6:162157200-162158000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
42	chr6:162157600-162158000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
43	chr6:162158000-162158400	Enhancers	Fetal Thymus	thymus
44	chr6:162158000-162165400	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
45	chr6:162161200-162161400	Enhancers	Duodenum Mucosa	Duodenum
46	chr6:162161400-162161800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
47	chr6:162161400-162161800	Flanking Active TSS	Duodenum Mucosa	Duodenum
48	chr6:162161800-162162600	Enhancers	Duodenum Mucosa	Duodenum
49	chr6:162161800-162163800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
50	chr6:162163800-162164000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links